OraSure Technologies Receives European Approval for Advance HIV Test
June 12, 2007
On Monday, OraSure Technologies announced it has received regulatory approval to market its Advance HIV 1/2 antibody test in the 27 nations of the European Union. The test can detect HIV-1 and HIV-2 antibodies in blood, plasma or oral fluid. It has already been approved by the U.S. Food and Drug Administration.
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.